Voya Investment Management LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 97.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 491,914 shares of the medical equipment provider's stock after purchasing an additional 242,468 shares during the period. Voya Investment Management LLC owned approximately 0.14% of Intuitive Surgical worth $200,028,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Bank of America Corp DE lifted its stake in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock worth $1,667,388,000 after purchasing an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth about $1,335,753,000. Amundi increased its position in shares of Intuitive Surgical by 8.6% during the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its position in shares of Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider's stock valued at $769,948,000 after purchasing an additional 184,044 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.
Insider Transactions at Intuitive Surgical
In other news, Director Craig Barratt sold 1,150 shares of the company's stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total transaction of $529,000.00. Following the completion of the transaction, the director directly owned 1,150 shares of the company's stock, valued at approximately $529,000. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the sale, the executive vice president owned 6,236 shares of the company's stock, valued at approximately $2,857,023.40. This represents a 6.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 39,302 shares of company stock valued at $17,708,685. Company insiders own 0.60% of the company's stock.
Intuitive Surgical Stock Down 1.6%
NASDAQ:ISRG opened at $430.53 on Wednesday. The company has a fifty day moving average of $420.62 and a 200 day moving average of $429.17. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The firm has a market capitalization of $149.24 billion, a P/E ratio of 52.06, a P/E/G ratio of 3.02 and a beta of 1.45.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to analysts' expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm's revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.40 EPS. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.
Wall Street Analyst Weigh In
ISRG has been the topic of a number of research reports. Raymond James Financial reissued an "outperform" rating and set a $480.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 21st. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Intuitive Surgical in a research note on Thursday, November 12th. UBS Group reiterated a "buy" rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. Royal Bank Of Canada reduced their price target on shares of Intuitive Surgical from $575.00 to $550.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 21st. Finally, JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $450.00 to $475.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $493.54.
View Our Latest Research Report on Intuitive Surgical
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.